THE CURRENT ROLE OF ANTIEMETIC DRUGS IN ONCOLOGY - A RECENT REVOLUTION IN PATIENT SYMPTOM CONTROL

被引：43

作者：

SAGAR, SM ^{[1
]}

机构：

[1] CANC TREATMENT & RES FDN NOVIA SCOTIA,HALIFAX B3H 1V7,NS,CANADA

来源：

CANCER TREATMENT REVIEWS | 1991年 / 18卷 / 02期

关键词：

D O I：

10.1016/0305-7372(91)90009-O

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：95 / 135

页数：41

共 253 条

[81]

EVANS B, 1991, EUR J CANCER S1, V27, pS26

[82]

EVANS C, 1991, EUR J CANCER S1, V27, pS25

[83]

FINE S, 1990, P AM SOC CLIN ONCOL, V9, P340

[84]

FLORCZYK AP, 1982, CANCER TREAT REP, V66, P187

[85]

FRASCHINI G, 1990, P AM SOC CLIN ONCOL, V9, P328

[86]

FRASCHINI G, 1991, EUR J CANCER S1, V27, pS26

[87]

FRIEDLANDER ML, 1983, LANCET, V2, P686

[88] MANAGEMENT OF NAUSEA AND VOMITING IN THE CANCER-PATIENT [J].

FRYTAK, S ;

MOERTEL, CG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1981, 245 (04) :393-396

[89] A RANDOMIZED TRIAL OF METOCLOPRAMIDE AND A COMBINATION OF DEXAMETHASONE AND LORAZEPAM FOR PREVENTION OF CHEMOTHERAPY-INDUCED VOMITING [J].

GAGEN, M ;

GOCHNOUR, D ;

YOUNG, D ;

GAGINELLA, T ;

NEIDHART, J .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (06) :696-701

[90] ANTIEMETIC ACTION OF 5-HT-3 RECEPTOR ANTAGONISTS - REVIEW OF PRECLINICAL AND CLINICAL-RESULTS WITH ICS 205-930 [J].

GAMSE, R .

CANCER TREATMENT REVIEWS, 1990, 17 (2-3) :301-305

← 4 5 6 7 8 9 10 11 12 13 →